Press releasePRNewswire
Perrigo
PRGO · NYSE
$16.17+$0.08 (+0.50%)TodayMarket closed ·
Prev close $16.09
Latest news
- NewsAvi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday
- News
Perrigo Q2 Adj. EPS $0.50 Beats $0.34 Estimate, Sales $1.023B Beat $1.013B Estimate
- Press releasePRNewswire
Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
- Press releasePRNewswire
Perrigo Announces Quarterly Dividend
- Press releasePRNewswire
Perrigo to Present at the Canaccord 46th Annual Growth Conference
- Press releasePRNewswire
Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
- Press releasePRNewswire
Perrigo Announces Appointment of Two New Independent Directors to Board
- NewsAvi Kapoor
Cramer Says Credo Technology Is 'Just So Good' — But Warns This Healthcare Name Is A 'Value Trap'
- NewsAvi Kapoor
Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- News
Perrigo Appoints Albert A. Manzone Interim President, CEO, Effective Immediately, Succeeding Patrick Lockwood-Taylor; Reaffirms FY26 Guidance
- Press releasePRNewswire
Perrigo Announces Leadership Transition
- Press releasePRNewswire
Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
- News
Perrigo Reports Q1 2026 Results: Full Earnings Call Transcript
- Press releasePRNewswire
Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations
- Press releasePRNewswire
Perrigo Completes Divestiture of Dermacosmetics Business
- Press releasePRNewswire
Perrigo Announces Quarterly Dividend
- Press releasePRNewswire
Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026
- News
FDA Takes Step Forward on Testosterone Therapy for Men
- Press releasePRNewswire
Perrigo to Present at the UBS Global Consumer and Retail Conference
- NewsAvi Kapoor
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releasePRNewswire
Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations
- Press releasePRNewswire
Perrigo Announces Quarterly Dividend
- Press releasePRNewswire
Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
- Press releasePRNewswire
PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm
- Press releasePRNewswire
Perrigo Company plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRGO
- Press releasePRNewswire
PRGO Deadline: PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
- Press releaseBusiness Wire
PRGO Deadline: Rosen Law Firm Urges Perrigo Company plc (NYSE: PRGO) Investors to Contact the Firm for Information About Their Rights
- Press releaseGlobe Newswire
PERRIGO FINAL CLASS ACTION DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Reminds Perrigo Company plc Investors of the Upcoming January 16th Deadline and Urges Investors to Contact the Firm
- Press releasePRNewswire
Perrigo Company plc Class Action: The Gross Law Firm Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - PRGO
- Press releasePRNewswire
Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- Press releaseGlobe Newswire
Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- Press releaseGlobe Newswire
DEADLINE ALERT for LRN, PRMB, FCX, and PRGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
- NewsAvi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
- Press releaseGlobe Newswire
DEADLINE ALERT for FCX, PRGO, JYD, STUB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
- Press releaseGlobe Newswire
DEADLINE ALERT for FCX, PRGO, JYD, STUB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
- Press releaseGlobe Newswire
DEADLINE ALERT for LRN, PRMB, FCX, and PRGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Urges DeFi, Skye Bioscience, and Perrigo Investors to Contact the Firm Regarding their Rights
- Press releasePRNewswire
Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations
- Press releasePRNewswire
Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations
- Press releasePRNewswire
Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations
- Press releasePRNewswire
Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations
- Press releasePRNewswire
/C O R R E C T I O N -- Perrigo Company plc/
- Press releasePRNewswire
Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.